LATEST

Ukraine war briefing: Kyiv targets Kremlin ‘shadow’ tankers as Russian strikes continue in capital●Hundreds of jobs at risk as John Lewis plans to cut some services●Switzerland beat Colombia on penalties to reach quarter-finals●Watch every penalty from Switzerland v Colombia shootout●Arbeloa appointed new Fulham boss●Switzerland break Colombian hearts with first shoot-out success●Victims of 23andMe data breach to get $47m payout, judge rules●Jim Carrey Classic The Cable Guy Coming to 4K Ultra HD Steelbook● Ukraine war briefing: Kyiv targets Kremlin ‘shadow’ tankers as Russian strikes continue in capital●Hundreds of jobs at risk as John Lewis plans to cut some services●Switzerland beat Colombia on penalties to reach quarter-finals●Watch every penalty from Switzerland v Colombia shootout●Arbeloa appointed new Fulham boss●Switzerland break Colombian hearts with first shoot-out success●Victims of 23andMe data breach to get $47m payout, judge rules●Jim Carrey Classic The Cable Guy Coming to 4K Ultra HD Steelbook●

Longevity

Popular joint supplement glucosamine linked to faster Alzheimer’s progression

Healthy Aging News -- ScienceDaily 10 June 2026, 05:17 UTC 10 Jun 2026

Popular joint supplement glucosamine linked to faster Alzheimer’s progression — Healthy Aging News -- ScienceDaily

A major study suggests glucosamine, a popular supplement for joint pain, could be linked to faster progression from mild cognitive impairment to Alzheimer’s disease. Researchers found a 25% higher likelihood of developing dementia among glucosamine users and uncovered biological clues that may explain why.

This story was reported by Healthy Aging News -- ScienceDaily. EUROPES curates Europe's most relevant coverage — read the full report at the original source.

Read full coverage at Healthy Aging News -- ScienceDaily →

More from Longevity

LG AI, D&D Pharmatech push AI-powered peptide drug discovery

Longevity.Technology · 9h ago

Rescuing Calcium Ion Homeostasis Extends Mouse Lifespan

Lifespan Research Institute · 10h ago

BioAge advances inflammaging drug into Phase 2

Longevity.Technology · 10h ago

AI-designed IPF drug advances to Phase III

Longevity.Technology · 13h ago

How Muscle Loss and Bone Loss Are Related

Lifespan Research Institute · 1d ago

RNA, AI and the end of one-size-fits-all nutrition

Longevity.Technology · 1d ago